These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7788338)
1. Bone tissue in rheumatoid arthritis (2). Pathophysiologic data, pathologic findings, and therapeutic implications. Cortet B; Flipo RM; Duquesnoy B; Delcambre B Rev Rhum Engl Ed; 1995 Mar; 62(3):205-11. PubMed ID: 7788338 [TBL] [Abstract][Full Text] [Related]
2. Is bone turnover a determinant of bone mass in rheumatoid arthritis? Cortet B; Flipo RM; Pigny P; Duquesnoy B; Boersma A; Marchandise X; Delcambre B J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427 [TBL] [Abstract][Full Text] [Related]
3. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy. Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763 [TBL] [Abstract][Full Text] [Related]
4. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Pullerits R; d'Elia HF; Tarkowski A; Carlsten H Rheumatology (Oxford); 2009 Jul; 48(7):785-90. PubMed ID: 19416946 [TBL] [Abstract][Full Text] [Related]
5. Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy. Touati G; Ruiz JC; Porquet D; Kindermans C; Prieur AM; Czernichow P J Rheumatol; 2000 May; 27(5):1287-93. PubMed ID: 10813303 [TBL] [Abstract][Full Text] [Related]
6. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis]. Garnero P; Delmas PD Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740 [TBL] [Abstract][Full Text] [Related]
7. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis. El Miedany YM; Abubakr IH; El Baddini M J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538 [TBL] [Abstract][Full Text] [Related]
9. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. D'Elia HF; Larsen A; Mattsson LA; Waltbrand E; Kvist G; Mellström D; Saxne T; Ohlsson C; Nordborg E; Carlsten H J Rheumatol; 2003 Jul; 30(7):1456-63. PubMed ID: 12858441 [TBL] [Abstract][Full Text] [Related]
10. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488 [TBL] [Abstract][Full Text] [Related]
11. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. Gough A; Sambrook P; Devlin J; Huissoon A; Njeh C; Robbins S; Nguyen T; Emery P J Rheumatol; 1998 Jul; 25(7):1282-9. PubMed ID: 9676757 [TBL] [Abstract][Full Text] [Related]
12. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169 [TBL] [Abstract][Full Text] [Related]
13. Estrogens in rheumatoid arthritis; the immune system and bone. Islander U; Jochems C; Lagerquist MK; Forsblad-d'Elia H; Carlsten H Mol Cell Endocrinol; 2011 Mar; 335(1):14-29. PubMed ID: 20685609 [TBL] [Abstract][Full Text] [Related]
14. The role of megakaryocytes in skeletal homeostasis and rheumatoid arthritis. Kacena MA; Horowitz MC Curr Opin Rheumatol; 2006 Jul; 18(4):405-10. PubMed ID: 16763462 [TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]. Forsblad d'Elia H; Christgau S; Mattsson LA; Saxne T; Ohlsson C; Nordborg E; Carlsten H Arthritis Res Ther; 2004; 6(5):R457-68. PubMed ID: 15380045 [TBL] [Abstract][Full Text] [Related]
16. Paraarticular trabecular bone loss at the ultradistal radius and increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. Tanaka K; Inaba M; Goto H; Nagata-Sakurai M; Sakai S; Yamada S; Ueda M; Ishimura E; Nishizawa Y J Rheumatol; 2006 Apr; 33(4):652-8. PubMed ID: 16583470 [TBL] [Abstract][Full Text] [Related]
17. Histomorphometry of periarticular bone in rheumatoid arthritis. Kröger H; Arnala I; Rehnberg V; Hämäläinen M; Alhava E Ann Chir Gynaecol; 1994; 83(1):56-62. PubMed ID: 8053640 [TBL] [Abstract][Full Text] [Related]
18. Possibilities of monitoring bone metabolism in ruminants--an overview of the methods in use. Liesegang A Acta Vet Scand Suppl; 2003; 97():23-8. PubMed ID: 14621392 [TBL] [Abstract][Full Text] [Related]
19. Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritis. Cremers SC; Lodder MC; Den Hartigh J; Vermeij P; Van Pelt P; Lems WF; Papapoulos SE; Dijkmans BA J Rheumatol; 2004 Sep; 31(9):1732-7. PubMed ID: 15338492 [TBL] [Abstract][Full Text] [Related]
20. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis. Wong PK; Young L; Vaile JH; Tan L; Bertouch JV; Bleasel JF; White C Intern Med J; 2004; 34(9-10):539-44. PubMed ID: 15482266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]